Scaffold Based Search on the Desferithiocin Archetype
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
Iron overload disorder and diseases where iron mismanagement plays a crucial role require orally available iron chelators with favourable pharmacokinetic and toxicity profile. Desferrithiocin (DFT), a tridentate and orally available iron chelator has a favourable pharmacokinetic profile but its use has been clinically restricted due to its nephrotoxic potential. The chemical architecture of the DFT has been naturally well optimized for better iron chelation and iron clearance from human biological system. Equally they are also responsible for its toxicity. Hence, subsequent research has been devoted to develop a non-nephrotoxic analogue of DFT without losing its iron clearance ability. The review has been designed to classify the compounds reported till date and to discuss the structure activity relationship with reference to modifications attempted at different positions over pyridine and thiazoline ring of DFT. Compounds are clustered under two major classes: (i) Pyridine analogues and (ii) phenyl analogue and further each class has been further subdivided based on the presence or absence and the number of hydroxy functional groups present over pyridine or phenyl ring of the DFT analogues. Finally a summary and few insights into the development of newer analogues are provided.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
|---|---|
| Enthalten in: |
Mini reviews in medicinal chemistry - 19(2019), 19 vom: 27., Seite 1564-1576 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Shyam, Mousumi [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 26.12.2019 Date Revised 08.01.2020 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.2174/1389557519666190301151151 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM294515216 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM294515216 | ||
| 003 | DE-627 | ||
| 005 | 20231225081640.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2174/1389557519666190301151151 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0981.xml |
| 035 | |a (DE-627)NLM294515216 | ||
| 035 | |a (NLM)30827237 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Shyam, Mousumi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Scaffold Based Search on the Desferithiocin Archetype |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 26.12.2019 | ||
| 500 | |a Date Revised 08.01.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
| 520 | |a Iron overload disorder and diseases where iron mismanagement plays a crucial role require orally available iron chelators with favourable pharmacokinetic and toxicity profile. Desferrithiocin (DFT), a tridentate and orally available iron chelator has a favourable pharmacokinetic profile but its use has been clinically restricted due to its nephrotoxic potential. The chemical architecture of the DFT has been naturally well optimized for better iron chelation and iron clearance from human biological system. Equally they are also responsible for its toxicity. Hence, subsequent research has been devoted to develop a non-nephrotoxic analogue of DFT without losing its iron clearance ability. The review has been designed to classify the compounds reported till date and to discuss the structure activity relationship with reference to modifications attempted at different positions over pyridine and thiazoline ring of DFT. Compounds are clustered under two major classes: (i) Pyridine analogues and (ii) phenyl analogue and further each class has been further subdivided based on the presence or absence and the number of hydroxy functional groups present over pyridine or phenyl ring of the DFT analogues. Finally a summary and few insights into the development of newer analogues are provided | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Iron Chelators | |
| 650 | 4 | |a desferrithiocin analogues | |
| 650 | 4 | |a fenton’s reaction | |
| 650 | 4 | |a iron toxicity | |
| 650 | 4 | |a pyridine analogues. | |
| 650 | 4 | |a siderophores. | |
| 650 | 7 | |a Benzene Derivatives |2 NLM | |
| 650 | 7 | |a Dihydropyridines |2 NLM | |
| 650 | 7 | |a Iron Chelating Agents |2 NLM | |
| 650 | 7 | |a Pyridines |2 NLM | |
| 650 | 7 | |a Thiazoles |2 NLM | |
| 650 | 7 | |a desferrithiocin |2 NLM | |
| 650 | 7 | |a UMA0K9OMKD |2 NLM | |
| 700 | 1 | |a Dev, Abhimanyu |e verfasserin |4 aut | |
| 700 | 1 | |a Sinha, Barij Nayan |e verfasserin |4 aut | |
| 700 | 1 | |a Jayaprakash, Venkatesan |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Mini reviews in medicinal chemistry |d 2001 |g 19(2019), 19 vom: 27., Seite 1564-1576 |w (DE-627)NLM121595404 |x 1875-5607 |7 nnns |
| 773 | 1 | 8 | |g volume:19 |g year:2019 |g number:19 |g day:27 |g pages:1564-1576 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2174/1389557519666190301151151 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 19 |j 2019 |e 19 |b 27 |h 1564-1576 | ||